TLR7/8 agonist 3

CAS No. 642473-95-8

TLR7/8 agonist 3( —— )

Catalog No. M26483 CAS No. 642473-95-8

TLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 262 Get Quote
10MG 434 Get Quote
25MG 710 Get Quote
50MG 972 Get Quote
100MG 1332 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TLR7/8 agonist 3
  • Note
    Research use only, not for human use.
  • Brief Description
    TLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.
  • Description
    TLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    SMARCA2| SMARCA4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    642473-95-8
  • Formula Weight
    313.405
  • Molecular Formula
    C17H23N5O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (159.54 mM)
  • SMILES
    CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wanior M, et, al. Pan-SMARCA/PB1 Bromodomain Inhibitors and Their Role in Regulating Adipogenesis. J Med Chem. 2020 Dec 10;63(23):14680-14699.
molnova catalog
related products
  • Loxoribine

    Loxoribine is a guanosine analog. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist. It has anti-viral and anti-tumor activities.Loxoribine is a potent new immunostimulant with a relatively broad spectrum of immunobiological activities.

  • BBIQ

    BBIQ is a powerful vaccine adjuvant that enhances innate immune responses and it is a imidazoquinoline compound and a potent and selectively toll-like receptor 7 (TLR7) agonist with an EC50 of 59.1 nM for human TLR7.

  • BMS-905

    BMS-905 is a potent dual inhibitors of TLR7 and TLR8 with good selectivity against TLR9 and other family members. BMS-905 can be used in studies about the treatment of diseases such as psoriasis, arthritis, and lupus.